Latest Announcements

City Union Bank's Board of Directors approved the date for its Annual General Meeting on August 14, 2026. They also declared a dividend of Rs. 2 per equity share (200% on face value Re. 1), with July 14, 2026, fixed as the record date for this payout. Additionally, the Board approved an enabling resolution to raise up to Rs. 500 crore through a Qualified Institutions Placement (QIP) route. This capital raise, pending member approval at the AGM, aims to strengthen the bank's capital base for future growth.

City Union Bank's Board of Directors approved the Annual General Meeting for August 14, 2026, and set July 31, 2026, as the record date for a 200% dividend (Rs. 2 per share). Additionally, the Board approved raising Rs. 500 crore through a Qualified Institutional Placement (QIP), subject to shareholder approval, to further bolster capital. This capital raise is crucial for the bank's future growth initiatives and balance sheet strength.

Bliss GVS Pharma Ltd has announced the record date for the payment of the final dividend for the financial year ended March 31, 2026. The record date for eligible shareholders is Wednesday, July 08, 2026. The company's register of members and share transfer books will be closed from July 09 to July 15, 2026. The 41st Annual General Meeting will also be held on July 15, 2026, where the dividend is expected to be approved and subsequently distributed by August 14, 2026.

Antarctica Limited announced the successful passing of four resolutions via postal ballot, including the crucial increase in authorised share capital and the appointment of Mr. Aryan Arvindbhai Prajapati as Executive Managing Director. The increase in authorised share capital, approved with 99.59% votes, provides flexibility for future capital raising. The appointment of the new MD, approved with 93.17% votes, signals a leadership change aimed at strategic direction and potential growth. These actions indicate corporate governance in action and preparation for future expansion.

Purple Finance Ltd has announced the receipt of a Letter of Offer dated June 20, 2026, from Allied Commodities Private Limited and Mr. Sandeep Jindal, along with persons acting in concert, for an open offer. The offer aims to acquire up to 1,76,48,152 equity shares, representing 26.00% of the target company's emerging voting capital, at a price of ₹55.00 per share, payable in cash. The offer is made under SEBI SAST Regulations and has secured prior approval from the Reserve Bank of India for the proposed acquisition and change in control of the company.

PNB Housing Finance Limited's MD & CEO and National Head-Corporate Planning & Investor Relations participated in a 'Hong Kong & Singapore Non-Deal Roadshow' on June 23, 2026. They held one-on-one meetings with institutional investors, including Balyasny Asset Management and Value Partners Group. Discussions focused on business strategy, margins, asset quality, and future outlook, based on information already disclosed to the exchanges. The company confirmed that no unpublished price sensitive information was shared during the meet.

Solara Active Pharma Sciences Limited has announced that Crisil Ratings Limited has upgraded its credit ratings for bank loan facilities totaling Rs. 791.2 Crore. The long-term rating has been upgraded to 'Crisil BBB+/Stable' from 'Crisil BBB/Stable', and the short-term rating has been upgraded to 'Crisil A2' from 'Crisil A3+'. This upgrade reflects an improvement in the company's financial risk profile and creditworthiness.

Suyog Telematics Limited has submitted the voting results for its postal ballot, which sought approval for the re-classification of a member from the "Promoter/Promoter Group" to the "Public" category. The company announced that the resolution was duly passed by its members with the requisite majority through remote e-voting. This reclassification may enhance public float and improve compliance with regulatory norms.

Bliss GVS Pharma Ltd has announced the book closure period from July 9, 2026, to July 15, 2026, for its 41st Annual General Meeting (AGM) and for the purpose of paying the final dividend for the financial year ended March 31, 2026. The record date for the final dividend is July 8, 2026. The dividend, if approved by members at the AGM on July 15, 2026, will be distributed to shareholders on or before August 14, 2026.

Ratnamani Metals & Tubes Limited has completed the subscription of its 75% equity shareholding in Ratnamani Middle East Company, LLC, a joint venture in Dammam, Kingdom of Saudi Arabia. The company invested SAR 1,500,000 for 75 equity shares, formalizing its majority stake. This JV, established with Saudi Electric Supply Company Limited, aims to provide critical tubing solutions and locally manufacture seamless products for the KSA and GCC markets. This move is a follow-up to previous intimations regarding the JV agreement and incorporation.

Aanchal Ispat Ltd's board has approved a preferential issue of up to 1,055,000 fully convertible warrants to its promoter category at a price of Rs. 82 per warrant, aiming to raise approximately Rs. 8.65 crore. These warrants will be convertible into equity shares within 18 months. The company also decided to amend its Articles of Association to allow for future issuance of various convertible securities. An Extraordinary General Meeting (EGM) is scheduled for July 23, 2026, to seek shareholder approval for these proposals.

Ratnamani Metals & Tubes Ltd has subscribed to 75 equity shares, investing SAR 1,500,000, in its subsidiary Ratnamani Middle East Company LLC in Saudi Arabia. This represents a 75% stake in the joint venture, formed with Saudi Electric Supply Company Limited, which aims to provide critical tubing solutions and locally manufacture seamless products for consumers in KSA and GCC countries. This action finalizes the company's equity contribution for establishing its presence in the Middle East market.

ARSS Infrastructure Projects Limited has secured a new work order valued at Rs. 21,46,82,069.00 (approximately Rs. 21.47 Crores) from the Office of the Superintending Engineer, Jagatsinghpur (R&B) Division. The contract involves the widening and strengthening of a road from Dengapola to Champahat in Jagatsinghpur district under a state plan. The project has a completion timeline of 16 months and was awarded after ARSS's bid came in 28% below the estimated cost.

ARSS Infrastructure Projects Ltd has received a domestic work order worth Rs. 21.47 Crores from the Office of the Superintending Engineer, Jagatsinghpur (R&B) Division, Odisha. The order is for the improvement, widening, and strengthening of roads in the Jagatsinghpur district under a state plan. The project has a stipulated completion period of 16 months and is expected to positively contribute to the company's revenue stream.

Honasa Consumer Ltd. announced the strategic acquisition of a 58% majority stake in Fluence Pharma, a science-backed nutraceuticals company known for its patented Cyclical Nutrition Therapy and dermatologist network. This acquisition marks Honasa's entry into the high-growth nutraceuticals category, specifically targeting "inside-out" beauty, under a newly formed subsidiary, Honasa Health. Fluence Pharma reported ~INR 40 Crore revenue and over 20% EBITDA margin in FY26, and Honasa aims to leverage Fluence's science with its own brand-building and digital distribution capabilities.

Bliss GVS Pharma Ltd announced its 41st Annual General Meeting (AGM) for July 15, 2026, to be held virtually. Key agenda items include the adoption of financial statements for FY2025-2026 and the re-appointment of its MD & CEO. Importantly, the Board has recommended a final dividend of INR 1.00 per equity share for the fiscal year. The record date for dividend entitlement is July 08, 2026, with payment expected by August 14, 2026, upon shareholder approval.

Honasa Consumer Limited (HCL) has announced the acquisition of a 58% majority stake in Fluence Pharma, a science-backed nutraceuticals company specializing in patented Cyclical Nutrition Therapy. This strategic move marks HCL's entry into the high-growth nutraceuticals market, particularly focusing on "inside-out" beauty solutions. HCL will establish a new subsidiary, Honasa Health Private Limited, to scale Fluence's B2C nutrition portfolio. Fluence Pharma reported approximately INR 40 Crore revenue with over 20% EBITDA margin in FY26.

City Union Bank Ltd's Board of Directors has approved its Annual General Meeting to be held on August 14, 2026. The bank also declared a dividend of Rs. 2 per equity share for FY 2026, with the record date set for July 31, 2026. Significantly, the Board has proposed to raise Rs. 500 crore through a Qualified Institutional Placement (QIP) route, subject to shareholder approval at the upcoming AGM, to augment its capital.

Honasa Consumer Ltd announced the acquisition of a 58% equity stake in Fluence Pharma Private Limited, a company offering condition-specific OTC supplements under brands like "Hair Fact, Skin Fact, and Pro Fact." The acquisition, valued at approximately ₹135 Crores enterprise value for the initial stake, strategically marks Honasa's entry into the high-growth nutraceuticals market, with plans to acquire the remaining 42% over the next 5-7 years. Additionally, Honasa will incorporate a wholly-owned subsidiary, 'Honasa Health Private Limited,' to manage its new B2C nutraceuticals operations.

Alivus Life Sciences Limited announced that institutional investors are scheduled to visit its plant in Ankleshwar, Gujarat, on June 29, 2026. This will be an in-person, group or one-on-one meeting. The disclosure is made pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Such interactions facilitate greater transparency and engagement with the investment community, allowing investors to gain direct insights into the company's operations and facilities.